Position in PCRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$49,479,922
+$4,670,361 QoQ
Shares Held
1,950,332
-1.6% QoQ
Ownership
4.89%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#6
of 251 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026D. E. Shaw & Co., Inc. holds $657,589,731 across 42 Drug Manufacturers - Specialty & Generic names. PCRX ranks #4 (7.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
|
1,267,706 | $101,074,198 | |
| 2 | ALKS |
Alkermes plc.
|
1,312,031 | $68,750,423 | |
| 3 | XERS |
Xeris Biopharma Holdings, Inc.
|
7,804,758 | $61,813,683 | |
| 4 | PCRX |
Pacira BioSciences, Inc.
This page
|
1,950,332 | $49,479,922 | |
| 5 | ZTS |
Zoetis Inc.
|
537,515 | $38,625,827 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
569,756 | $36,435,896 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
767,668 | $35,704,237 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,049,467 | $32,852,956 |
All Filings in PCRX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $49,479,922 | 1,950,332 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $44,809,561 | 1,982,724 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $52,793,310 | 2,039,927 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $50,049,025 | 1,942,143 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $53,855,423 | 2,253,365 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $56,258,137 | 2,263,909 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $42,530,809 | 2,257,474 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $29,451,916 | 1,956,938 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $13,745,102 | 480,430 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $7,025,627 | 240,439 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $6,950,979 | 206,016 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $4,818,662 | 157,062 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $212,731 | 5,309 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $776,695 | 19,032 | Shares | Defined | 2023-05-15 | |
| 2022-03-31 | $889,204 | 11,651 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,990,268 | 49,697 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $4,465,048 | 79,733 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $9,861,894 | 162,523 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $41,950,897 | 598,529 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $51,340,086 | 857,956 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $52,444,599 | 872,332 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $50,916,100 | 970,385 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $35,105,339 | 1,046,983 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||